Skip to main content

Global Cell Sorting Market: Projected to Grow at 8% CAGR with Rising Demand in Precision Medicine by 2030

 


The global cell sorting market is set to witness a growth rate of 8% in the next 5 years. increasing research in life sciences and genomics; technological advancements in cell sorting; rising prevalence of chronic and infectious diseases; and increasing government funding and investments in biopharmaceutical R&D; are some of the key factors driving the cell sorting market

Cell sorting is a laboratory technique used to separate and isolate specific cells from a heterogeneous population based on their physical, chemical, or biological properties. It enables researchers to analyze and study targeted cell types for various applications, including drug discovery, immunology, stem cell research, and cancer studies. Common methods include fluorescence-activated cell sorting (FACS), magnetic-activated cell sorting (MACS), and microfluidic-based sorting. By providing high purity and viability of sorted cells, this technology plays a critical role in advancing precision medicine, facilitating immunotherapies, and supporting basic and clinical research in life sciences and biotechnology.

🔗 Want deeper insights? Download the sample report:

https://meditechinsights.com/cell-sorting-market/request-sample/

Increasing research in life sciences and genomics to propel market demand

The rising prevalence of chronic and infectious diseases is driving the cell sorting market by increasing the demand for advanced diagnostic and therapeutic solutions. Conditions like cancer, diabetes, and autoimmune disorders require precise identification and isolation of specific cell types for research and treatment development. Similarly, infectious diseases like HIV and COVID-19 necessitate studying immune responses at the cellular level, where cell sorting plays a critical role. By enabling detailed cellular analysis, cell sorting supports advancements in immunotherapy, vaccine development, and personalized medicine, fueling market growth. The urgent need for innovative healthcare solutions continues to boost the adoption of this technology.

Increasing research activities on cell sorting technologies are driving the market growth

Increasing research in life sciences and genomics fuels the cell sorting market by driving demand for technologies that precisely isolate and analyze individual cells. As researchers delve deeper into single-cell sequencing, transcriptomics, and proteomics, high-resolution sorting becomes essential for uncovering cellular heterogeneity and understanding gene expression patterns. Enhanced funding and technological advancements, including fluorescence-activated and microfluidics-based sorters, enable rapid, accurate cell separation. This trend supports breakthroughs in personalized medicine, cancer diagnostics, and regenerative therapies, ultimately accelerating discovery and improving clinical outcomes. Thus, the expansion of life sciences research in genomics directly propels market growth for advanced cell sorting solutions.

Competitive Landscape Analysis

The global cell sorting market is marked by the presence of established and emerging market players such as Becton, Dickinson and Company (BD Biosciences), Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., Sony Biotechnology Inc., Thermo Fisher Scientific Inc., Miltenyi Biotec, DH Life Sciences, LLC, Union Biometrica, Inc., On-chip Biotechnologies Co., Ltd., and Cytonome/ST LLC; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and geographic expansion.

Gain a competitive edge-request a sample report now! 

https://meditechinsights.com/cell-sorting-market/request-sample/

Global Cell Sorting Market Segmentation

This report by Medi-Tech Insights provides the size of the global cell sorting market at the regional- and country-level from 2023 to 2030. The report further segments the market based on technology, product & service, application, end user.

  • Market Size & Forecast (2023-2030), By Technology, USD Million
    • Fluorescence-Activated Cell Sorting (FACS)
    • Magnetic-Activated Cell Sorting (MACS)
    • Microfluidics-Based Cell Sorting
    • Others
  • Market Size & Forecast (2023-2030), By Product & Service, USD Million
    • Cell Sorters
    • Cell Sorting Reagents and Consumables
    • Cell Sorting Services
  • Market Size & Forecast (2023-2030), By Application, USD Million
    • Research Applications
      • Immunology & Cancer Research
      • Stem Cell Research
      • Drug Discovery
      • Other Research Applications
    • Clinical Applications
  • Market Size & Forecast (2023-2030), By End User, USD Million
    • Research Institutions
    • Medical Schools and Academic Institutions
    • Pharmaceutical and Biotechnology Companies
    • Hospitals and Clinical Testing Laboratories
    • Others
  • Market Size & Forecast (2023-2030), By Region, USD Million
    • North America
      • US
      • Canada
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • India
      • Japan
      • Rest of Asia Pacific
    • Latin America
    • Middle East & Africa

About Medi-Tech Insights

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.

Contact:

Ruta Halde
Associate, Medi-Tech Insights
 +32 498 86 80 79
 info@meditechinsights.com 

Comments

Post a Comment

Popular posts from this blog

Global Biotechnology Market to grow at 13–15% CAGR as CRISPR use expands globally by 2029

  The global biotechnology market is set to witness a growth rate of 13-15% in the next 5 years.  Advancements in genetic engineering and genomics; growing demand for biopharmaceuticals; rising incidence of chronic diseases; growth in environmental and agricultural biotechnology; increased investment in R&D; growing demand for synthetic biology; and presence of favorable government initiatives are some of the key factors driving the biotechnology market. Biotechnology is the scientific field that uses biological organisms, systems, or processes to develop products and technologies aimed at improving health, agriculture, environmental sustainability, and industrial efficiency. By applying principles of genetics, molecular biology, and biochemistry, biotechnology enables advancements like genetic engineering, biopharmaceutical development, biofuels, and genetically modified organisms (GMOs). This field is instrumental in producing therapies for diseases, increasing crop r...
Post a Comment
Read more

Global Multi Cancer Early Detection Market expanding 15–20% CAGR through personalized care 2030

  The multi cancer early detection market is expected to grow at a CAGR of around 15-20% during the forecast period.  This growth is primarily due to the rising awareness and increasing demand for early-stage screening tools, especially as cancer rates continue to rise globally, and technological advancements in screening methods. However, high costs and strict regulations can still hinder the market growth.  Multi Cancer Early Detection (MCED) refers to tests designed to detect multiple cancers, often from a single blood sample, unlike traditional methods, which can include multiple diagnostic tests or biopsies. These tests look for signs like DNA methylation patterns or small traces of tumor DNA floating in the bloodstream. The primary goal is early cancer detection, ideally before any symptoms appear, so the overall treatment is more effective and less expensive. Download a free sample report now 👉 https://meditechinsights.com/multi-cancer-early-detection-marke...
Post a Comment
Read more

Global Structural Heart Devices Market growth 9% CAGR with favorable reimbursement scenarios 2030

  The global structural heart devices market is set to witness a CAGR of ~9% in the next 5 years.  The rising geriatric population & corresponding rise in the prevalence of heart disease, technological advancements in structural heart devices, regulatory approval for expanded indications for several transcatheter heart valves, and increasing awareness and favorable reimbursements for these procedures in key markets are some of the pivotal factors driving the growth of the structural heart devices market. However, high device costs, complex procedures, and stringent regulatory hurdles continue to restrain market uptake.  Structural heart disease occurs when something is wrong with one’s heart valves, walls, chambers or muscles. It exists from birth or develops as one age. It includes conditions such as congenital heart disease, cardiomyopathy, and heart valve disease. Heart valve devices, occluders & delivery systems, annuloplasty rings, heart access systems, cl...
Post a Comment
Read more